Richard de Boer

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Journal of Clinical Oncology · 2007 · 386 citations

Medicine, Pharmacology, Pharmacotherapy +17

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

Robert E. Coleman, Richard de Boer, Holger Eidtmann et al. · Annals of Oncology · 2012 · 337 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study

Holger Eidtmann, Richard de Boer, Nigel Bundred et al. · Annals of Oncology · 2010 · 280 citations

Medicine, Oncology, Pharmacotherapy +15

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial

Aaron S. Mansfield, Andrzej Każarnowicz, Nina Karaseva et al. · Annals of Oncology · 2020 · 190 citations · Full text

Medicine, Oncology, Pharmacology +17

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Clinical Cancer Research · 2008 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17